Sentence examples for the commercialisation process from inspiring English sources

Could you "shadow" them as they pursue this or get involved in the commercialisation process?

R&D staff aspire to perfection in each of their innovations, which delays the commercialisation process.

Even in the USA, there is some evidence that the involvement of TTOs may slow down the commercialisation process due to a keenness to safeguard researchers' interests and maximise university returns (Siegel et al. 2007).

MaRS is the brainchild of leaders in Canada's academic, business, and scientific communities who were inspired to create a central facility for all of the major players in the commercialisation process: industry, venture capital, IP and patent lawyers, and funding agencies.

The Medical and Related Sciences Discovery District (MaRS), which is rising on a muddy plot of land in the midst of Toronto's research and health sciences centre, "was created to address the bottlenecks that exist in the commercialisation process in Canada," thereby accelerating innovation, explains John Cook, president and chief operating officer of the nonprofit MaRS corporation.

Since 1992, the exploitation is granted to "cofradı́as" after presentation of an annual plan of exploitation and management, where fishing (daily allocation of effort, maximum individual quotas and area of exploitation), surveillance and the commercialisation processes are established.

The commercial success of candy hardcore acts like Vengaboys - of "We Like to Party" fame - perfectly illustrates this commercialisation process, and it's no surprise that they're listed alongside Nederland Zingt and Piet himself in Thunderdome's Hall of Shame.

The second block of the Impact Assessment Framework in Fig. 4 dwells on the output of commercialisation process that TTOs use in taking IPs from their universities/PRIs to the market.

Chinese UREs try to perform all three roles at once, integrating several stages of the research, development and commercialisation process into one organisational entity (Kroll and Liefner 2008).

While licensing number and revenue are useful and relevant indicators to measure commercialisation process efficiency, several issues have been raised about their adequacy in reflecting the economic benefits of public-funded research.

Such views assume the effective transfer of newly developed products or services to a market willing to transact for the innovative products at a price that sustains the research, development and commercialisation processes behind the initial investments.